Product Program year 2021 Source: CMS Open Payments

Essure

Device Women's Health

PDI 00888853030517

Open in the dashboard

General payments

$59,025

20 payments

Research payments

$605,814

237 payments

Through program year 2021, $59,025 in general payments and $605,814 in research payments were reported against Essure (Women's Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $59,025 20
2021 Research $605,814 237

Breakdown

Who paid General payments · program year 2021
  1. Bayer HealthCare Pharmaceuticals Inc. $59,025 20 payments
Top recipients General payments · program year 2021
  1. James Simon Gynecology · Washington, DC $24,000 41% · 1 payment
  2. Merrill Gershwin Rheumatology · Davis, CA $14,250 24% · 4 payments
  3. Phillip Lieberman Allergy & Immunology · Memphis, TN $8,625 15% · 2 payments
  4. James Liu Reproductive Endocrinology · Cleveland, OH $6,900 12% · 3 payments
  5. Stephen Wasserman Allergy & Immunology · La Jolla, CA $2,100 4% · 1 payment

The top 5 of 9 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Gynecology Obstetrics & Gynecology $24,000 41% · 1 practitioner
  2. Rheumatology Internal Medicine $14,250 24% · 1 practitioner
  3. Allergy & Immunology $10,725 18% · 2 practitioners
  4. Reproductive Endocrinology Obstetrics & Gynecology $6,900 12% · 1 practitioner
  5. Obstetrics & Gynecology $2,800 5% · 3 practitioners

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. District of Columbia $24,000 41% · 1 recipient
  2. California $16,350 28% · 2 recipients
  3. Tennessee $8,625 15% · 1 recipient
  4. Ohio $7,600 13% · 2 recipients
  5. Michigan $1,050 2% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

20 general · 237 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record